LH · XBRL financial data

Labcorp Holdings financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (LH's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Revenue	3,033*	3,177	3,221	3,282	3,329*	3,345	3,527	3,564	3,516*	3,538	3,731	3,810
Cost of revenue	2,212*	2,279	2,295	2,378	2,433*	2,397	2,481	2,538	2,523*	2,524	2,619	2,702
Gross profit	821*	897	926	904	896*	948	1,046	1,025	993*	1,014	1,112	1,108
Selling, general and administrative	533*	508	558	569	595*	546	579	552	539*	551	577	611
Operating income (loss)	(123)*	321	295	254	217*	326	395	397	268*	381	452	402
Interest expense	49*	47	48	50	63*	56	57	56	55*	55	61	59
Other income (expense)	18*	20	20	4	16*	(1)	(33)	(2)	(19)*	(13)	(4)	(5)
Income tax expense (benefit)	20*	69	62	41	40*	62	66	76	26*	42	87	65
Net income (loss)	(167)*	228	205	169	143*	213	238	261	165*	278	299	263
Earnings per share, basic USD per share	(1.97)*	2.71	2.44	2.02	1.72*	2.54	2.85	3.14	1.99*	3.37	3.66	3.24
Earnings per share, diluted USD per share	(1.96)*	2.69	2.43	2.00	1.70*	2.52	2.84	3.12	1.98*	3.35	3.64	3.22
Weighted average shares, basic millions of shares	85*	84	84	84	83*	84	83	83	83*	82	82	81
Weighted average shares, diluted millions of shares	85*	85	84	84	84*	84	84	84	83*	83	82	82

Balance sheet

CSV

Fiscal quarters (LH's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Cash and cash equivalents	537	99	265	1,517	1,519	369	647	598	532	981	142	262
Accounts receivable	1,913	2,084	2,089	2,059	1,944	2,123	2,121	2,109	2,104	2,289	2,342	2,413
Inventory	475	475	442	483	493	488	508	522	535	498	562	538
Prepaid and other current assets	—	—	—	—	698	—	—	—	693	630	606	607
Total current assets	3,765	3,457	3,571	4,910	4,807	3,790	4,087	4,079	4,021	4,559	3,815	3,966
Property and equipment, net	2,912	2,898	2,933	3,050	3,045	3,091	3,134	3,113	3,082	3,066	3,101	3,143
Right-of-use asset	737	—	—	—	785	—	—	—	804	—	—	—
Goodwill	6,143	6,219	6,220	6,482	6,370	6,421	6,551	6,682	6,790	6,955	7,030	7,177
Total assets	16,725	16,531	16,712	18,613	18,379	17,604	18,060	18,262	18,393	19,087	18,532	18,925
Accounts payable	828	696	761	661	876	718	793	669	841	696	689	738
Accrued liabilities	804	649	708	758	871	770	836	878	848	852	862	890
Current portion of long-term debt	—	—	—	—	1,000	—	—	—	500	500	1	601
Total current liabilities	3,225	3,942	4,065	3,412	3,330	2,065	2,717	2,629	2,824	2,641	2,125	2,820
Long-term debt	4,055	3,048	3,047	5,352	5,331	5,569	5,077	5,083	5,085	5,834	5,858	5,251
Lease liability, non-current	649	625	643	701	676	696	713	692	683	657	661	675
Total liabilities	8,835	8,556	8,692	10,427	10,313	9,282	9,571	9,549	9,756	10,342	9,909	10,061
Retained earnings	7,888	8,055	8,178	8,276	8,303	8,456	8,498	8,698	8,640	8,784	8,701	8,905
Total stockholders' equity	7,875	7,960	8,006	8,170	8,052	8,307	8,473	8,697	8,620	8,729	8,607	8,848
Total liabilities and equity	16,725	16,531	16,712	18,613	18,379	17,604	18,060	18,262	18,393	19,087	18,532	18,925
Common shares outstanding (cover page) millions of shares	≈84	84	84	84	84	84	83	83	82	82	81	81

≈ Rounded on cover: the filing states this count rounded, and it sits more than 1% off the weighted shares for the period.

Cash flows

CSV

Fiscal quarters (LH's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Net income (loss)	(167)*	228	205	169	143*	213	238	261	165*	278	299	263
Stock-based compensation	27*	32	31*	27*	27*	33	34*	29*	30*	32	35*	31*
Depreciation and amortization	146*	155	157*	162*	171*	167	170*	171*	173*	173	179*	183*
Net cash from operating activities	580*	(30)	561*	277*	777*	19	621*	387*	614*	192	446*	564*
Purchases of property and equipment	167*	134	128*	116*	112*	126	78*	107*	124*	121	132*	152*
Net cash from investing activities	(331)*	(393)	(185)*	(579)*	(210)*	(336)	(94)*	(374)*	(390)*	(322)	(366)*	(434)*
Share repurchases	(9)*	—	—	75*	75*	0	200*	25*	225*	98	354*	0*
Dividends paid	61*	62	60*	61*	60*	62	60*	60*	59*	61	59*	58*
Net cash from financing activities	(447)*	(12)	(210)*	1,548*	(547)*	(840)	(267)*	(60)*	(290)*	581	(920)*	(10)*
Net change in cash	(191)*	(438)	166*	1,252*	1*	(1,149)	278*	(49)*	(66)*	449	(839)*	120*

Compare with peers

SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Labcorp Holdings	262	3,810	564*	81.2M	—	Q3 FY26 10-QSep 30, 2026
Natera	1,092	753	55*	144.1M	—	Q2 FY26 10-QJun 30, 2026
Quest Diagnostics	797	3,097	611*	110.0M	—	Q3 FY26 10-QSep 30, 2026
Exact Sciences	956	878*	152*	190.9M	—	Q4 FY25 10-KDec 31, 2025
Guardant Health	1,053	335	(58)*	134.2M	18.2 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.